Of the 321 companies exhibiting at the North American Spine Society (NASS) Annual Meeting next month, around 50 consider OEMs to be their primary source of revenue.
Alphatec Spine, Globus Medical and NuVasive, the three largest pure-play spine companies, announced revised manufacturing strategies during 2Q15 earnings calls.
Are you heading to NASS next month?
Below, we present spine-centric reading to help you prepare.
"Our first step is to allow orthopaedic implant companies to manufacture patient specific implants in a more cost effective, faster way with higher quality. We think we can do that within three to five years."
Augment is approved for use in ankle and/or hindfoot fusion, and is expected by management to reach $10 million to $12 million in U.S. sales in its first seven to eight months on the market.
The model's newly-acquired applications, TrayTouch® and Virtual Backtable®, will allow central processing and OR administrators to identify the instruments that a surgeon uses during a procedure, to assemble and prepare the instrument trays and to train OR staff using visual layouts of each tray.
